Streptococcus pneumoniae induces SPLUNC1 and the regulatory effects of resveratrol
SHANG Yan-Ping, LIN Li, LI Chang-Chong
Department of Pediatric Pulmonology, Second Affiliated Hospital/Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China
Abstract Objective To investigate the host-defense role of short palate, lung, and nasal epithelium clone 1 (SPLUNC1) in Streptococcus pneumoniae (SP) infection and the effect of resveratrol (Res) on SPLUNC1 expression, and to provide new thoughts for the treatment of diseases caused by SP infection. Methods According to the multiplicity of infection (MOI), BEAS-2B cells with SP infection were divided into control group, MOI20 SP group, and MOI50 SP group. According to the different concentrations of Res, the BEAS-2B cells with MOI20 SP infection pretreated by Res were divided into 12.5Res+SP group, 25Res+SP group, and 50Res+SP group (the final concentrations of Res were 12.5, 25, and 50 μmol/L, respectively). Cell Counting Kit-8 was used to measure cell activity and determine the optimal concentration and action time of SP and Res. In the formal experiment, the cells were divided into control group, Res group, SP group, and Res+SP group. Real-time PCR and ELISA were used to measure the mRNA and protein expression of SPLUNC1. Results Over the time of SP infection, cell activity tended to decrease. Compared with the control group and the MOI20 SP group, the MOI50 SP group had a reduction in cell activity. Compared with the MOI20 SP group, the 25Res+SP group had increased cell activity and the 50Res+SP group had reduced cell activity (P < 0.05). MOI20 SP bacterial suspension and 25 μmol/L Res were used for the formal experiment. Over the time of SP infection, the mRNA expression of SPLUNC1 in BEAS-2B cells firstly increased and then decreased in the SP group and the Res+SP group (P < 0.05). Compared with the SP group, the Res+SP group had significant increases in the mRNA and protein expression of SPLUNC1 at all time points (P < 0.05). Compared with the control group, the Res group had no significant changes in the mRNA and protein expression of SPLUNC1 (P > 0.05). Conclusions SP infection can induce SPLUNC1 expression and the host-defense role of SPLUNC1. Res can upregulate SPLUNC1 expression during the development of infection and enhance cell protection in a concentration- and time-dependent manner.
Yao KH, Yang YH. Streptococcus pneumoniae diseases in Chinese children:past, present and future[J]. Vaccine, 2008, 26(35):4425-4433.
[2]
Denapaite D, Brückner R, Hakenbeck R, et al. Biosynthesis of teichoic acids in Streptococcus pneumoniae and closely related species:lessons from genomes[J]. Microb Drug Resist, 2012, 18(3):344-358.
[3]
McGillivary G, Bakaletz LO. The multifunctional host defense peptide SPLUNC1 is critical for homeostasis of the mammalian upper airway[J]. PLoS One, 2010, 5(10):e13224.
[4]
Britto CJ, Liu Q, Curran DR, et al. Short palate, lung, and nasal epithelial clone-1 is a tightly regulated airway sensor in innate and adaptive immunity[J]. Am J Respir Cell Mol Biol, 2013, 48(6):717-724.
[5]
Di YP. Functional roles of SPLUNC1 in the innate immune response against Gram-negative bacteria[J]. Biochem Soc Trans, 2011, 39(4):1051-1055.
[6]
Ning F, Wang C, Berry KZ, et al. Structural characterization of the pulmonary innate immune protein SPLUNC1 and identification of lipid ligands[J]. FASEB J, 2014, 28(12):5349-5360.
[7]
Lee M, Kim S, Kwon OK, et al. Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma[J]. Int Immunopharmacol, 2009, 9(4):418-424.
[8]
Miki H, Uehara N, Kimura A, et al. Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells[J]. Int J Oncol, 2012, 40(4):1020-1028.
[9]
Yuan Y, Xue X, Guo RB, et al. Resveratrol enhances the antitumor effects of temozolomide in glioblastoma via ROS-dependent AMPK-TSC-mTOR signaling pathway[J]. CNS Neurosci Ther, 2012, 18(7):536-546.
[10]
Hathaway LJ, Brugger SD, Morand B, et al. Capsule type of Streptococcus pneumoniae determines growth phenotype[J]. PLoS Pathog, 2012, 8(3):e1002574.
[11]
Blumental S, Granger-Farbos A, Moïsi JC, et al. Virulence factors of Streptococcus pneumoniae. Comparison between African and French invasive isolates and implication for future vaccines[J]. PLoS One, 2015, 10(7):e0133885.
[12]
Sayeed S, Nistico L, St Croix C, et al. Multifunctional role of human SPLUNC1 in Pseudomonas aeruginosa infection[J]. Infect Immun, 2013, 81(1):285-291.
[13]
Liu Y, Di ME, Chu HW, et al. Increased susceptibility to pulmonary Pseudomonas infection in Splunc1 knockout mice[J]. J Immunol, 2013, 191(8):4259-4268.
[14]
Gally F, Di YP, Smith SK, et al. SPLUNC1 promotes lung innate defense against Mycoplasma pneumoniae infection in mice[J]. Am J Pathol, 2011, 178(5):2159-2167.
[15]
Chu HW, Thaikoottathil J, Rino JG, et al. Function and regulation of SPLUNC1 protein in Mycoplasma infection and allergic inflammation[J]. J Immunol, 2007, 179(6):3995-4002.
[16]
Liu Y, Bartlett JA, Di ME, et al. SPLUNC1/BPIFA1 contributes to pulmonary host defense against Klebsiella pneumoniae respiratory infection[J]. Am J Pathol, 2013, 182(5):1519-1531.
[17]
Hobbs CA, Blanchard MG, Alijevic O, et al. Identification of the SPLUNC1 ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airway epithelial cultures[J]. Am J Physiol Lung Cell Mol Physiol, 2013, 305(12):L990-L1001.
